YU49496B - 2,4-disulfophenyl butyl nitrone, its salts, and their use as pharmaceuticals - Google Patents

2,4-disulfophenyl butyl nitrone, its salts, and their use as pharmaceuticals

Info

Publication number
YU49496B
YU49496B YU42395A YU42395A YU49496B YU 49496 B YU49496 B YU 49496B YU 42395 A YU42395 A YU 42395A YU 42395 A YU42395 A YU 42395A YU 49496 B YU49496 B YU 49496B
Authority
YU
Yugoslavia
Prior art keywords
nervous system
central nervous
salts
disulfophenyl
pharmaceuticals
Prior art date
Application number
YU42395A
Other languages
Serbo-Croatian (sh)
Other versions
YU42395A (en
Inventor
John M. Carney
Original Assignee
Oklahoma Medical Research Foundation
University Of Kentucky Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oklahoma Medical Research Foundation, University Of Kentucky Research Foundation filed Critical Oklahoma Medical Research Foundation
Priority to YU42395A priority Critical patent/YU49496B/en
Publication of YU42395A publication Critical patent/YU42395A/en
Publication of YU49496B publication Critical patent/YU49496B/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

Opisan jc 2.4-disulfo a-fenil-tert-butil nitron i njegove farmaceutski prihvatljive soli. Ovi su materijali korisni kao farmaceutska sredstva za oralno ili perenteralno, na primer intravensko, davanje pacijentima koji pate od akutne oksidacije centralnog nervnog sistema, sto se javlja kod mozdanog udara, ili od postepene oksidacije centralnog nervnog sistema, koja se moze iskazati kao progresivni gubitak funkcije centralnog nervnog sistema. Materijali se takode mogu koristiti za ublazavanje nezeljenog delovanja lekova za kancerozna oboljenja koji izazivaju oksidaciona ostecenja.Prijava sadrži još 1 nezavisan i 1 zavisan patentni zahtev2.4-Disulfo [alpha] -phenyl-tert-butyl nitron and its pharmaceutically acceptable salts are described. These materials are useful as pharmaceutical agents for oral or perenteral, for example, intravenous, administration to patients suffering from acute oxidation of the central nervous system, occurring in stroke, or from gradual oxidation of the central nervous system, which may be manifested as progressive loss of function of the central nervous system. The materials can also be used to alleviate the undesirable effects of cancerous drugs that cause oxidative damage. The application contains 1 more independent and 1 dependent claim

YU42395A 1995-06-21 1995-06-21 2,4-disulfophenyl butyl nitrone, its salts, and their use as pharmaceuticals YU49496B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
YU42395A YU49496B (en) 1995-06-21 1995-06-21 2,4-disulfophenyl butyl nitrone, its salts, and their use as pharmaceuticals

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
YU42395A YU49496B (en) 1995-06-21 1995-06-21 2,4-disulfophenyl butyl nitrone, its salts, and their use as pharmaceuticals

Publications (2)

Publication Number Publication Date
YU42395A YU42395A (en) 1998-08-14
YU49496B true YU49496B (en) 2006-08-17

Family

ID=47598467

Family Applications (1)

Application Number Title Priority Date Filing Date
YU42395A YU49496B (en) 1995-06-21 1995-06-21 2,4-disulfophenyl butyl nitrone, its salts, and their use as pharmaceuticals

Country Status (1)

Country Link
YU (1) YU49496B (en)

Also Published As

Publication number Publication date
YU42395A (en) 1998-08-14

Similar Documents

Publication Publication Date Title
MX9204268A (en) A COMPOSITION FOR THE PROLONGED AND CONTROLLED RELEASE OF MEDICINAL SUBSTANCES AND A PROCESS TO PREPARE THE SAME.
KR870005637A (en) Drug depot
FI962589A0 (en) 2,4-Disulfophenylbutylnitrone, its salts and their use as pharmaceuticals
ES2157307T3 (en) TOPICAL COMPOSITION CONTAINING A SUBSTANCE ANTAGONIST P.
ME00416B (en) Celecoxib compositions
ES2161288T3 (en) COMPRESSED CLOSED WITH POLYMER THAT INCLUDES AMOXYCLINE AND CLAVULANATE.
CL2004001191A1 (en) COMPOUNDS DERIVED FROM STEROIDS 17 ALPHA-FLUORO RENTED, WITH ANTIGESTAGENA ACTIVITY; PHARMACEUTICAL COMPOSITION; PHARMACEUTICAL COMBINATION; AND USE OF THE COMPOUND IN THE PREPARATION OF AN ANTIESTROGENIC MEDICINAL PRODUCT, FOR THE TREATMENT OF DISMENORREA
ES2116447T3 (en) A PHARMACEUTICAL COMPOSITION CONTAINING A DEFINED LIPID SYSTEM.
TW355683B (en) Composition containing micronized nebivolol
ATE270544T1 (en) SEMI-SOLID MEDICINAL PREPARATION CONTAINING ISOTRETINOIN
NZ501950A (en) Medicinal compositions for application to mucosa
UA29469C2 (en) Liposomal pharmaceutical compositions for intravenous administration
BR0007294A (en) Improved pharmaceutical formulations
DE69923336D1 (en) ORANGE BUPRENORPHINIC MEDICINAL PRODUCTS TO BE APPLIED
RS49599B (en) Use of h+, k+ -atpaze inhibitors and glucocortifoids and pharmaceutical formulation
NL193820B (en) Solid pharmaceutical dosage form for oral administration of Ibuprofen.
AR011437A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF MIGRANES AND THE USE OF THE SAME IN THE PREPARATION OF A MEDICINAL PRODUCT.
YU49496B (en) 2,4-disulfophenyl butyl nitrone, its salts, and their use as pharmaceuticals
MA26788A1 (en) PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION OF PHLOROGLUCINOL AND THEIR PREPARATION
DE69626401D1 (en) MEDICINAL PRODUCTS FOR TOPICAL USE
PT1144420E (en) PHOSPHATIDILINOSITOIS SULPHATATED TO ITS PREPARATION AND ITS UTILIZATION
TR199901237T2 (en) A new therapeutic application of a thienylcyclohexylamine derivative.
ES2128353T3 (en) TOPIC COMPOSITION CONTAINING PENCICLOVIR.
ES2188670T3 (en) FORMULATIONS CONTAINING CODEINA.
ATE227984T1 (en) AGENTS AGAINST MALARIA AND BABESIA AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME